Rare diseases
Investigational molecules
Locations
Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
BelgiumStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
BelgiumStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
BelgiumStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
BelgiumStudy on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes
BelgiumStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
BelgiumStudy of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy
BelgiumStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
BelgiumStudy on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
BelgiumStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
BelgiumStudy Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumStudy on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
